Alison A. Armour - Net Worth and Insider Trading
Alison A. Armour Net Worth
The estimated net worth of Alison A. Armour is at least $2 Million dollars as of 2024-11-29. Alison A. Armour is the Chief Medical Officer of Endocyte Inc and owns about 101,040 shares of Endocyte Inc (ECYT) stock worth over $2 Million. Details can be seen in Alison A. Armour's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Alison A. Armour has not made any transactions after 2018-10-05 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Alison A. Armour
Alison A. Armour Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Alison A. Armour owns 2 companies in total, including Halozyme Therapeutics Inc (HALO) , and Endocyte Inc (ECYT) .
Click here to see the complete history of Alison A. Armour’s form 4 insider trades.
Insider Ownership Summary of Alison A. Armour
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| HALO | Halozyme Therapeutics Inc | 2019-05-06 | SVP & Research & Development |
| ECYT | Endocyte Inc | 2018-12-21 | Chief Medical Officer |
Alison A. Armour Latest Holdings Summary
Alison A. Armour currently owns a total of 1 stock. Alison A. Armour owns 101,040 shares of Endocyte Inc (ECYT) as of October 5, 2018, with a value of $2 Million.
Latest Holdings of Alison A. Armour
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| ECYT | Endocyte Inc | 2018-10-05 | 101,040 | 23.99 | 2,423,950 |
Holding Weightings of Alison A. Armour
Alison A. Armour Form 4 Trading Tracker
According to the SEC Form 4 filings, Alison A. Armour has made a total of 0 transactions in Endocyte Inc (ECYT) over the past 5 years. The most-recent trade in Endocyte Inc is the sale of 9,111 shares on October 5, 2018, which brought Alison A. Armour around $141,767.
Insider Trading History of Alison A. Armour
- 1
Alison A. Armour Trading Performance
Alison A. Armour Ownership Network
Alison A. Armour Owned Company Details
What does Halozyme Therapeutics Inc do?
Who are the key executives at Halozyme Therapeutics Inc?
Alison A. Armour is the SVP & Research & Development of Halozyme Therapeutics Inc. Other key executives at Halozyme Therapeutics Inc include SVP & Chief Technical Officer Michael J. Labarre , director & President and CEO Helen Torley , and SVP & Chief Financial Officer Nicole Labrosse .
Halozyme Therapeutics Inc (HALO) Insider Trades Summary
Over the past 18 months, Alison A. Armour made no insider transaction in Halozyme Therapeutics Inc (HALO). Other recent insider transactions involving Halozyme Therapeutics Inc (HALO) include a net sale of 280,000 shares made by Michael J. Labarre , a net sale of 200,000 shares made by Helen Torley , and a net sale of 49,881 shares made by Matthew L. Posard .
In summary, during the past 3 months, insiders sold 120,000 shares of Halozyme Therapeutics Inc (HALO) in total and bought 0 shares, with a net sale of 120,000 shares. During the past 18 months, 584,881 shares of Halozyme Therapeutics Inc (HALO) were sold and 0 shares were bought by its insiders, resulting in a net sale of 584,881 shares.
Halozyme Therapeutics Inc (HALO)'s detailed insider trading history can be found in Insider Trading Tracker table.
Halozyme Therapeutics Inc Insider Transactions
Alison A. Armour Mailing Address
Above is the net worth, insider trading, and ownership report for Alison A. Armour. You might contact Alison A. Armour via mailing address: C/o Endocyte, Inc., 3000 Kent Avenue, Suite A1-100, West Lafayette In 47906.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
